In addition, to characterize the changes in the pain system, other biomarkers should be measured including sensory neuropeptides (i.e., nerve growth factor (NGF)) and mediators along the NF-κB pathway, which have been implicated in chronic inflammatory pain conditions such as arthritis [42, 43]. This evidence concerns the gene NFKB1 and Arthritis.